A tirzepatide COA (Certificate of Analysis) is an essential quality document detailing the molecular identity, chemical purity, and biological cleanliness of a specific production lot. Valid certificates report reverse-phase high-performance liquid chromatography (RP-HPLC) purity exceeding 99%, mass spectrometry identity confirmation matching 4813.5 Da, and bacterial endotoxin levels. PX1 Research provides batch-specific documentation for every lot to ensure consistent, reproducible preclinical data.
A tirzepatide COA (Certificate of Analysis) is an essential quality document detailing the molecular identity, chemical purity, and biological cleanliness of a specific production lot. Valid certificates report reverse-phase high-performance liquid chromatography (RP-HPLC) purity exceeding 99%, mass spectrometry identity confirmation matching 4813.5 Da, and bacterial endotoxin levels. PX1 Research provides batch-specific documentation for every lot to ensure consistent, reproducible preclinical data.
In laboratory settings investigating dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonism, analytical precision is paramount. A lot-specific tirzepatide COA serves as the definitive reference document validating that a synthetic peptide sequence conforms strictly to structural and chemical specifications prior to experimental application.
When conducting quantitative in vitro cell signaling assays or in vivo metabolic studies, uncharacterized impurities can alter receptor binding kinetics, introduce cellular toxicity, or obscure downstream signaling events. Requesting and reviewing a complete tirzepatide certificate of analysis ensures investigators eliminate variables caused by peptide truncation, residual synthesis solvents, or microbial contamination. Investigators can examine verified lot documentation through the PX1 research database.
Tirzepatide is a 39-amino-acid synthetic peptide engineered with a C20 fatty diacid acyl chain attached via a linker to a lysine residue at position 20. This complex, branched structure requires rigorous analytical verification. A complete certificate of analysis for the tirzepatide research peptide documents key chemical properties that confirm structural integrity.
Primary analytical attributes reported on an authentic certificate of analysis include chemical formula (C225H348N48O68), exact theoretical molecular weight (4813.53 Da), observed mass via spectrometry, chromatographic purity percentage, physical appearance (a dense white lyophilized cake), net peptide content, and endotoxin quantification. Each parameter confirms that the material is suitable for high-precision laboratory research.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the standard method for establishing peptide purity. During RP-HPLC testing, the peptide sample is eluted through a hydrophobic stationary phase using an organic solvent gradient, separating the primary target peptide from synthesis byproducts such as deletion sequences, diastereomers, and truncated fragments.
On a standard tirzepatide COA, the HPLC chromatogram displays peak retention times and integration values. Purity is calculated as the area percentage of the main target peak relative to the total integrated area of all detected peaks. For robust preclinical studies, researchers should mandate an HPLC purity profile of 99% or higher. Detailed methodology on analytical separation can be explored in our technical guide on RP-HPLC purity testing protocols.
While RP-HPLC establishes chemical purity, Mass Spectrometry (MS)—typically Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization (ESI-MS)—is required to confirm molecular identity. HPLC alone cannot distinguish a target peptide from an isomer or closely matched impurity with an identical retention time.
The MS spectrum published on a tirzepatide certificate of analysis displays the mass-to-charge ratio (m/z) of the ionized peptide. For tirzepatide, the observed monoisotopic or average mass peak must closely match the theoretical molecular mass of 4813.5 Da. Discrepancies in mass indicate incorrect amino acid sequencing, incomplete side-chain deprotection, or failure to properly attach the C20 fatty diacid moiety.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens capable of skewing experimental outcomes. In vitro cell culture models and primary tissue assays are highly sensitive to endotoxins, which trigger inflammatory cytokine cascades independently of peptide-receptor interaction.
High-quality tirzepatide batch documentation incorporates Limulus Amebocyte Lysate (LAL) testing to quantify endotoxin units per milligram (EU/mg). Quality research standards require endotoxin levels below 0.01 EU/mg to prevent non-specific cellular activation. Learn more about the impact of pyrogens on experimental models in our overview of endotoxin testing standards.
Evaluating supplier documentation requires understanding the differences between comprehensive third-party lab testing and incomplete internal summaries. Below is a comparative assessment of analytical standards across research suppliers:
• Third-Party ISO 17025 Accreditation: High-grade suppliers provide independent, third-party laboratory reports. Low-grade suppliers often rely on internal batch summaries without external verification. • RP-HPLC Integration: High-grade COAs feature full-scale chromatographic traces with baseline integration. Substandard documents show cropped graphs or single reported numbers without raw data. • Mass Spectrometry Traces: Rigorous reports include full m/z spectrum graphs confirming 4813.5 Da mass identity. Inadequate reports omit MS data entirely. • Quantitative Endotoxin Results: Certified lots explicitly state LAL assay results (e.g., <0.005 EU/mg). Inferior sources mark endotoxin status as 'N/A' or unverified. • Lot Traceability: Authentic documents list unique manufacturing lot numbers matching the physical vial label for seamless auditing.
When designing comparative incretin studies, investigators evaluate multi-target agonists against single-receptor analogues. Tirzepatide represents a dual GIP/GLP-1 receptor agonist, requiring specialized structural verification due to its acylated peptide backbone. In contrast, mono-agonists like the semaglutide research compound target only the GLP-1 receptor, featuring a distinct 31-amino-acid chain and single fatty acid side-chain.
Broader multi-receptor studies also evaluate triple-agonist candidates such as retatrutide (GIP/GLP-1/Glucagon) or dual-pathway combinations involving cagrilintide (an amylin analogue). Because these molecules share overlapping secondary structures and modification strategies, rigorous lot-specific certificates of analysis are critical to prevent cross-contamination and ensure target specificity during comparative in vitro trials.
Lyophilized tirzepatide exhibits strong stability when stored under controlled temperature regimes. Upon receipt, unopened vials should be stored at -20°C or -80°C in a desiccated environment protected from light exposure to prevent moisture accumulation and hydrolytic degradation.
Repeated freeze-thaw cycles must be avoided as temperature fluctuations induce peptide aggregation and peptide bond cleavage, compromising structural integrity. For extended shelf-life recommendations and temperature handling matrices, consult our laboratory guide on lyophilized peptide storage guidelines.
Reconstitution protocols must preserve the secondary structure of the acylated peptide. Standard laboratory preparation involves reconstituting the lyophilized cake using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream assay.
Diluent should be directed down the glass wall of the vial rather than sprayed directly onto the peptide cake. Gentle swirling is recommended to achieve complete dissolution; violent agitation or vortexing must be avoided to prevent protein foaming and denaturation. For precise concentration calculations, refer to our peptide reconstitution calculator guide.
PX1 Research operates strictly within GMP-compliant, ISO 17025 accredited analytical frameworks. Every batch of synthetic peptide manufactured for PX1 undergoes stringent raw material clearance, automated solid-phase peptide synthesis (SPPS), double-purification RP-HPLC, and individual vial lot-number assignment.
We ship directly from centralized fulfillment facilities in California and Arizona, offering same-day dispatch for orders received Monday through Friday before cut-off times. Research institutions requiring high-volume orders or dedicated supply agreements can establish customized institutional arrangements via PX1 wholesale lab accounts.
What is a tirzepatide coa?
A tirzepatide COA (Certificate of Analysis) is an official analytical document issued by an independent laboratory detailing the identity, purity, molecular weight, and cleanliness testing (such as HPLC, MS, and LAL endotoxin assays) for a specific manufacturing lot.
Where can I find a verified tirzepatide certificate of analysis?
Verified certificates of analysis are provided directly on the product listing or via lot lookup databases for research suppliers like PX1 Research, where third-party ISO 17025 analytical reports are matched to specific vial batch numbers.
What purity level should a tirzepatide COA show for laboratory research?
A valid tirzepatide COA should confirm an RP-HPLC purity level of 99.0% or higher. High purity ensures experimental reproducibility and eliminates interference from truncated peptide fragments or chemical impurities.
How does mass spectrometry verify tirzepatide identity on a COA?
Mass spectrometry (MS) measures the mass-to-charge ratio of the peptide. The observed molecular mass on the COA must match tirzepatide's theoretical mass of approximately 4813.5 Da to confirm correct sequence synthesis and fatty acid acylation.
Why is endotoxin testing included on a tirzepatide certificate of analysis?
Endotoxin testing via Limulus Amebocyte Lysate (LAL) assay ensures the peptide is free of bacterial pyrogens. High endotoxin levels can induce non-specific inflammatory responses in cellular assays and preclinical models, compromising data validity.
What molecular weight should appear on a tirzepatide coa?
The theoretical molecular weight reported on a tirzepatide COA should be 4813.53 g/mol (Da). Observed mass spectrometry values typically fall within ±1 Da of this theoretical target.
How should lyophilized tirzepatide be stored once received by the lab?
Lyophilized tirzepatide should be stored at -20°C or lower in a dry, dark location. Stored under desiccated, sub-zero conditions, the un-reconstituted peptide remains stable for extended laboratory research durations.
What solvent is recommended for reconstituting tirzepatide for in vitro assays?
Reconstitution is typically performed using sterile Bacteriostatic Water or laboratory-grade Phosphate-Buffered Saline (PBS, pH 7.4). Solvents should be selected based on cell line compatibility and downstream assay parameters.
How does tirzepatide analytical data compare to semaglutide COA metrics?
While both peptides require >99% HPLC purity and low endotoxin levels, tirzepatide's molecular mass (4813.5 Da) is distinct from semaglutide (4113.6 Da) due to differences in amino acid sequence length and C20 vs. C18 fatty acid chain modifications.
Can research institutions request custom lot testing or bulk COA verification?
Yes, research institutions and universities can request dedicated batch analysis, custom aliquoting, and complete raw chromatographic data files by establishing institutional wholesale research accounts with PX1 Research.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.